As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...